Original Contribution

PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2)

Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial

Inger R. de Ridder, Heleen M. den Hertog, H. Maarten A. van Gemert, A.H.C.M.L. (Tobien) Schreuder, Annemieke Ruitenberg, E. (Lisette) Maasland, Ritu Saxena, Jordie H. van Tuijl, Ben P.W. Jansen, Renske M. Van den Berg-Vos, Frederique Vermeij, Peter J. Koudstaal, L. Jaap Kappelle, Ale Algra, H. Bart van der Worp, Diederik W.J. Dippel
https://doi.org/10.1161/STROKEAHA.116.015957
Stroke. 2017;STROKEAHA.116.015957
Originally published March 13, 2017

  • Data Supplement

    Files in this Data Supplement:

Jump to

Current Issue

Stroke
April 2018, Volume 49, Issue 4

Article Tools

  • Print
  • Citation Tools
  • Article Alerts
  • Save to my folders

Share this Article

  • Email
  • PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2)
    Inger R. de Ridder, Heleen M. den Hertog, H. Maarten A. van Gemert, A.H.C.M.L. (Tobien) Schreuder, Annemieke Ruitenberg, E. (Lisette) Maasland, Ritu Saxena, Jordie H. van Tuijl, Ben P.W. Jansen, Renske M. Van den Berg-Vos, Frederique Vermeij, Peter J. Koudstaal, L. Jaap Kappelle, Ale Algra, H. Bart van der Worp and Diederik W.J. Dippel
    Stroke. 2017;STROKEAHA.116.015957, originally published March 13, 2017
    https://doi.org/10.1161/STROKEAHA.116.015957
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects